chr4-83295935-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098540.3(HPSE):c.1473-432T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.635 in 152,098 control chromosomes in the GnomAD database, including 32,144 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.63 ( 32144 hom., cov: 32)
Consequence
HPSE
NM_001098540.3 intron
NM_001098540.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.308
Publications
4 publications found
Genes affected
HPSE (HGNC:5164): (heparanase) Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.846 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HPSE | NM_001098540.3 | c.1473-432T>C | intron_variant | Intron 11 of 11 | ENST00000311412.10 | NP_001092010.1 | ||
| HPSE | NM_006665.6 | c.1473-432T>C | intron_variant | Intron 12 of 12 | NP_006656.2 | |||
| HPSE | NM_001199830.1 | c.1299-432T>C | intron_variant | Intron 10 of 10 | NP_001186759.1 | |||
| HPSE | NM_001166498.3 | c.1251-432T>C | intron_variant | Intron 10 of 10 | NP_001159970.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.635 AC: 96474AN: 151980Hom.: 32138 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
96474
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.635 AC: 96507AN: 152098Hom.: 32144 Cov.: 32 AF XY: 0.643 AC XY: 47827AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
96507
AN:
152098
Hom.:
Cov.:
32
AF XY:
AC XY:
47827
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
17372
AN:
41478
American (AMR)
AF:
AC:
10365
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2270
AN:
3470
East Asian (EAS)
AF:
AC:
4498
AN:
5184
South Asian (SAS)
AF:
AC:
3506
AN:
4826
European-Finnish (FIN)
AF:
AC:
8492
AN:
10544
Middle Eastern (MID)
AF:
AC:
179
AN:
292
European-Non Finnish (NFE)
AF:
AC:
47841
AN:
67996
Other (OTH)
AF:
AC:
1383
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1647
3294
4940
6587
8234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2710
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.